HK92089A - Improvements in or relating to cephalosporin derivatives - Google Patents

Improvements in or relating to cephalosporin derivatives

Info

Publication number
HK92089A
HK92089A HK920/89A HK92089A HK92089A HK 92089 A HK92089 A HK 92089A HK 920/89 A HK920/89 A HK 920/89A HK 92089 A HK92089 A HK 92089A HK 92089 A HK92089 A HK 92089A
Authority
HK
Hong Kong
Prior art keywords
relating
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
HK920/89A
Other languages
English (en)
Inventor
Gary Lowell Engel
Joseph Michael Indelicato
Harry Albert Rose
Lawrence Joseph Mcshane
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK92089A publication Critical patent/HK92089A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK920/89A 1983-12-01 1989-11-16 Improvements in or relating to cephalosporin derivatives HK92089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/556,887 US4600773A (en) 1983-12-01 1983-12-01 Crystalline cephalexin hydrochloride monohydrate

Publications (1)

Publication Number Publication Date
HK92089A true HK92089A (en) 1989-11-24

Family

ID=24223233

Family Applications (1)

Application Number Title Priority Date Filing Date
HK920/89A HK92089A (en) 1983-12-01 1989-11-16 Improvements in or relating to cephalosporin derivatives

Country Status (46)

Country Link
US (1) US4600773A (ko)
EP (1) EP0143658B1 (ko)
JP (1) JPS60132990A (ko)
KR (1) KR870000527B1 (ko)
AT (1) AT390616B (ko)
AU (1) AU566080B2 (ko)
BE (1) BE901142A (ko)
BG (1) BG40966A3 (ko)
BR (1) BR8406037A (ko)
CH (1) CH661732A5 (ko)
CS (1) CS248725B2 (ko)
CY (1) CY1505A (ko)
DD (1) DD229410A5 (ko)
DE (1) DE3443065A1 (ko)
DK (1) DK158354C (ko)
ES (1) ES8602011A1 (ko)
FI (1) FI80274C (ko)
FR (1) FR2555990B1 (ko)
GB (1) GB2150566B (ko)
GR (1) GR81043B (ko)
GT (1) GT198400146A (ko)
HK (1) HK92089A (ko)
HU (1) HU192516B (ko)
IE (1) IE57886B1 (ko)
IL (1) IL73639A (ko)
IN (1) IN163078B (ko)
IT (1) IT1177329B (ko)
JO (1) JO1347B1 (ko)
LU (1) LU85650A1 (ko)
MA (1) MA20279A1 (ko)
MX (1) MX159670A (ko)
MY (1) MY102966A (ko)
NL (1) NL8403588A (ko)
NO (1) NO844711L (ko)
NZ (1) NZ210357A (ko)
OA (1) OA07876A (ko)
PH (1) PH20849A (ko)
PL (1) PL146014B1 (ko)
PT (1) PT79553B (ko)
SE (1) SE464026B (ko)
SG (1) SG59789G (ko)
SU (1) SU1251807A3 (ko)
YU (1) YU45680B (ko)
ZA (1) ZA849224B (ko)
ZM (1) ZM6384A1 (ko)
ZW (1) ZW19084A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
US20040033262A1 (en) * 2002-08-19 2004-02-19 Orchid Health Care Sustained release pharmaceutical composition of a cephalosporin antibiotic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS50151890A (ko) * 1974-05-30 1975-12-06
CH642850A5 (it) * 1978-10-20 1984-05-15 Ausonia Farma Srl Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
DK158354C (da) 1990-10-01
NL8403588A (nl) 1985-07-01
GT198400146A (es) 1986-05-20
YU45680B (sh) 1992-07-20
SE8405954L (sv) 1985-06-02
CY1505A (en) 1990-08-03
BR8406037A (pt) 1985-08-27
FR2555990B1 (fr) 1986-12-26
AU566080B2 (en) 1987-10-08
KR870000527B1 (ko) 1987-03-14
DE3443065A1 (de) 1985-06-20
IN163078B (ko) 1988-08-06
IL73639A0 (en) 1985-02-28
DK561284D0 (da) 1984-11-27
GB2150566B (en) 1987-08-26
GR81043B (en) 1985-03-27
PH20849A (en) 1987-05-08
IE843033L (en) 1985-06-01
JPS60132990A (ja) 1985-07-16
HU192516B (en) 1987-06-29
PL250593A1 (en) 1985-07-30
SG59789G (en) 1989-12-29
NO844711L (no) 1985-06-03
ES538019A0 (es) 1985-11-01
FI80274C (fi) 1990-05-10
FI844631L (fi) 1985-06-02
IT8423746A1 (it) 1986-05-27
NZ210357A (en) 1988-05-30
ZM6384A1 (en) 1985-07-22
BE901142A (fr) 1985-05-28
MX159670A (es) 1989-08-02
IT1177329B (it) 1987-08-26
SE8405954D0 (sv) 1984-11-26
JO1347B1 (en) 1986-11-30
CS248725B2 (en) 1987-02-12
OA07876A (fr) 1986-11-20
MA20279A1 (fr) 1985-07-01
ZW19084A1 (en) 1985-06-12
DD229410A5 (de) 1985-11-06
MY102966A (en) 1993-03-31
DK158354B (da) 1990-05-07
PL146014B1 (en) 1988-12-31
FR2555990A1 (fr) 1985-06-07
EP0143658B1 (en) 1989-03-22
DE3443065C2 (ko) 1989-03-23
ES8602011A1 (es) 1985-11-01
EP0143658A2 (en) 1985-06-05
PT79553A (en) 1984-12-01
AU3589784A (en) 1985-06-06
KR850004765A (ko) 1985-07-27
PT79553B (en) 1986-12-15
YU199684A (en) 1987-02-28
SU1251807A3 (ru) 1986-08-15
EP0143658A3 (en) 1986-02-12
IE57886B1 (en) 1993-05-05
IL73639A (en) 1988-06-30
CH661732A5 (de) 1987-08-14
HUT35685A (en) 1985-07-29
AT390616B (de) 1990-06-11
JPH0548234B2 (ko) 1993-07-20
IT8423746A0 (it) 1984-11-27
US4600773A (en) 1986-07-15
GB2150566A (en) 1985-07-03
SE464026B (sv) 1991-02-25
LU85650A1 (fr) 1985-07-17
GB8430073D0 (en) 1985-01-09
FI844631A0 (fi) 1984-11-26
DK561284A (da) 1985-06-02
FI80274B (fi) 1990-01-31
ATA373284A (de) 1989-11-15
ZA849224B (en) 1986-07-30
BG40966A3 (en) 1987-03-14

Similar Documents

Publication Publication Date Title
GB2141778B (en) Improvements in or relating to hinges
IL70075A0 (en) Improvements in or relating to 3-aryl-5-pyrazole derivatives
GB8403474D0 (en) Cephalosporin derivatives
GB2145408B (en) Improvements in or relating to preparing sodium cefuroxime
PT78685B (en) Cephalosporin derivatives
PT78985A (en) Improvements in or relating to cephalosporins
GB2155654B (en) Improvements in or relating to eyeguards
GR80670B (en) Improvements on or relating to 3-bicyclic pyridinium-methyl cephalosporin
IL73639A0 (en) Improvements in or relating to cephalosporin derivatives
GB2149122B (en) Improvements in or relating to sensors
GB2149121B (en) Improvements in or relating to sensors
DE3474532D1 (en) Improvements in or relating to trailers
GB2145899B (en) Improvements in or relating to telecines
GB2137997B (en) Improvements in or relating to indolylglycyl cephalosporin derivatives
ZW4384A1 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
GB2149123B (en) Improvements in or relating to sensors
IL71496A0 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
ZM1684A1 (en) Improvements in or relating to naphthylglycyl cephalosporin derivatives
GB2146768B (en) Improvements in or relating to surveying techniques
IL71500A0 (en) Improvements in or relating to naphthylglycyl cephalosporin derivatives
GB8409379D0 (en) Naphthylglycyl cephalosporin derivatives
IL70854A0 (en) Improvements in or relating to benzazepine derivatives
GB2137137B (en) Improvements in or relating to jigs
IL68500A0 (en) Improvement in or relating to naphthalenamine derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)